Accumulating evidence indicates that neutralizing antibodies play an important role in protection from chronic hepatitis C virus (HCV) infection. Efforts to elicit such responses by immunization with intact heterodimeric E1E2 envelope proteins have met with limited success. To determine whether antigenic sites, which are not exposed by the combined E1E2 heterodimer structure, are capable of eliciting neutralizing antibody responses, we expressed and purified each as separate recombinant proteins E1 and E2, from which the immunodominant hypervariable region (HVR-1) was deleted. Immunization of chimpanzees with either E1 or E2 alone induced antigen-specific T-helper cytokines of similar magnitude. Unexpectedly, the capacity to neutralize HCV was observed in E1 but not in animals immunized with E2 devoid of HVR-1. Furthermore, in vivo only E1-vaccinated animals exposed to the heterologous HCV-1b inoculum cleared HCV infection.

Original publication

DOI

10.1093/infdis/jir423

Type

Journal article

Journal

J Infect Dis

Publication Date

15/09/2011

Volume

204

Pages

837 - 844

Keywords

Animals, Antibodies, Neutralizing, Disease Models, Animal, Genotype, Hepacivirus, Hepatitis C, Pan troglodytes, Vaccines, Synthetic, Viral Envelope Proteins, Viral Hepatitis Vaccines